Chinese health: intends to acquire 46.01% equity of Yangzuhuimin for 133 million yuan.

Chinese Health Announcement: The company plans to purchase 46.01% of Yangzu Huimin's equity for 133 million yuan, 46.01% of Haihua Pharmaceutical's equity for 125 million yuan, and 70.01% of Tonglu Yishengtang's equity for 68.2598 million yuan. After the completion of this transaction, the target companies will be included in the company's consolidated financial statements. The company plans to use its own funds and part of the raised funds to make payments. If the approval for the change in the use of raised funds is not granted, all payments will be made using the company's own funds.